Home Tags China Development Industrial Bank

China Development Industrial Bank

Anbogen Therapeutics, a clinical-stage biotechnology company specializing in groundbreaking cancer drug development, today announced the successful completion of its Series A funding round. The lead investor is China Development Industrial Bank, with significant contributions from Taian Venture Capital, Maxpro and the National Development Fund (Business Angel Investment Program, and Implementation Project for Strengthening Investment in SMEs), with a total investment of approximately 12.5 million.

Anbogen Therapeutics Secures 12.5 Mn Series A Funding

Startup Rise -
© Copyright startuprise 2024 All Rights Reserved.
Exit mobile version